MA23254A1 - Procede de preparation de nouveaux composes - Google Patents
Procede de preparation de nouveaux composesInfo
- Publication number
- MA23254A1 MA23254A1 MA23564A MA23564A MA23254A1 MA 23254 A1 MA23254 A1 MA 23254A1 MA 23564 A MA23564 A MA 23564A MA 23564 A MA23564 A MA 23564A MA 23254 A1 MA23254 A1 MA 23254A1
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- new compounds
- compounds
- new
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Eyeglasses (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939313913A GB9313913D0 (en) | 1993-07-06 | 1993-07-06 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA23254A1 true MA23254A1 (fr) | 1995-04-01 |
Family
ID=10738344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA23564A MA23254A1 (fr) | 1993-07-06 | 1994-07-04 | Procede de preparation de nouveaux composes |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5834494A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0707581B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPH08512299A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1129937A (cg-RX-API-DMAC7.html) |
| AP (1) | AP463A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE149163T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU7228394A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2166624A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69401823T2 (cg-RX-API-DMAC7.html) |
| GB (1) | GB9313913D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL110204A0 (cg-RX-API-DMAC7.html) |
| MA (1) | MA23254A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW297023B (cg-RX-API-DMAC7.html) |
| WO (1) | WO1995001976A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA944807B (cg-RX-API-DMAC7.html) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5618824A (en) * | 1994-03-09 | 1997-04-08 | Merrell Pharmaceuticals Inc. | Treatment of obsessive-compulsive disorders with 5-HT2 antagonists |
| GB9414139D0 (en) * | 1994-07-13 | 1994-08-31 | Smithkline Beecham Plc | Novel compounds |
| GB9420521D0 (en) * | 1994-10-12 | 1994-11-30 | Smithkline Beecham Plc | Novel compounds |
| BR9607016A (pt) * | 1995-02-02 | 1997-10-28 | Smithkline Beecham Plc | Derivados de indol como antagonísta de receptor 5-ht |
| WO1996023769A2 (en) * | 1995-02-02 | 1996-08-08 | Smithkline Beecham Plc | Heterocyclic compounds possessing 5ht2c receptor antagonist activity |
| GB9517559D0 (en) * | 1995-08-26 | 1995-10-25 | Smithkline Beecham Plc | Novel compounds |
| CA2253941A1 (en) * | 1996-05-16 | 1997-11-20 | Sumanas Rakhit | Thiophene- and furan-tryptamine derivatives |
| GB9612883D0 (en) * | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
| GB9612885D0 (en) * | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
| US6362009B1 (en) | 1997-11-21 | 2002-03-26 | Merck & Co., Inc. | Solid phase synthesis of heterocycles |
| FR2778662B1 (fr) * | 1998-05-12 | 2000-06-16 | Adir | Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP1122252A4 (en) * | 1998-10-16 | 2002-06-26 | Takeda Chemical Industries Ltd | CONDENSED HEREROCYCLIC NITROGEN COMPOUNDS; MANUFACTURING PROCESS AND AGENTS CONTAINING THEM |
| US6453357B1 (en) | 1999-01-07 | 2002-09-17 | Cisco Technology, Inc. | Method and system for processing fragments and their out-of-order delivery during address translation |
| US6465467B1 (en) | 1999-05-21 | 2002-10-15 | Biovitrum Ab | Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
| ES2252004T3 (es) * | 1999-05-21 | 2006-05-16 | Biovitrum Ab | Nuevos compuestos, su uso y preparacion. |
| UA77650C2 (en) | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
| FR2810979B1 (fr) * | 2000-06-29 | 2002-08-23 | Adir | Nouveaux derives de diphenyluree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| GB0019950D0 (en) * | 2000-08-12 | 2000-09-27 | Smithkline Beecham Plc | Compounds |
| SE0004245D0 (sv) | 2000-11-20 | 2000-11-20 | Pharmacia Ab | Novel compounds and their use |
| EP1304589A1 (en) * | 2001-07-09 | 2003-04-23 | Alcatel | Connector for optical fibers |
| US6861440B2 (en) | 2001-10-26 | 2005-03-01 | Hoffmann-La Roche Inc. | DPP IV inhibitors |
| FR2837823B1 (fr) * | 2002-03-27 | 2005-04-08 | Servier Lab | Nouveaux derives d'indoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| NZ536664A (en) | 2002-06-19 | 2007-07-27 | Biovitrum Ab | Piperazinylpyrazine derivative compounds, their use and preparation |
| BRPI0411509A (pt) | 2003-06-20 | 2006-07-25 | Hoffmann La Roche | compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para tratamento e/ou profilaxia de enfermidades que estão associadas com dpp-iv e sua utilização |
| EA009591B1 (ru) | 2003-06-20 | 2008-02-28 | Ф.Хоффманн-Ля Рош Аг | Производные пиридо[2,1-а]изохинолина в качестве ингибиторов dpp-iv |
| AR058040A1 (es) * | 2005-09-13 | 2008-01-23 | Bayer Cropscience Ag | Derivados plaguicidas de fenilamidina sustituida con feniloxi |
| US8293100B2 (en) | 2009-03-13 | 2012-10-23 | Terrasep, Llc | Methods and apparatus for centrifugal liquid chromatography |
| CN106278987A (zh) * | 2016-08-16 | 2017-01-04 | 都创(上海)医药科技有限公司 | 吲哚啉类化合物的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4428881A (en) * | 1977-12-23 | 1984-01-31 | Gulf Oil Corporation | Control of unwanted vegetation with N-carbamylindolines |
| KR930702334A (ko) * | 1990-09-13 | 1993-09-08 | 데이비드 로버트 | 5 하이드록시트립타민 수용체 길항제로서의 인돌우레아 |
| CA2142721A1 (en) * | 1992-08-20 | 1994-03-03 | Ian T. Forbes | Condensed indole derivatives as 5ht and 5ht antagonists |
-
1993
- 1993-07-06 GB GB939313913A patent/GB9313913D0/en active Pending
-
1994
- 1994-06-30 AU AU72283/94A patent/AU7228394A/en not_active Abandoned
- 1994-06-30 CN CN94193185A patent/CN1129937A/zh active Pending
- 1994-06-30 WO PCT/EP1994/002148 patent/WO1995001976A1/en not_active Ceased
- 1994-06-30 CA CA002166624A patent/CA2166624A1/en not_active Abandoned
- 1994-06-30 JP JP7503812A patent/JPH08512299A/ja active Pending
- 1994-06-30 EP EP94921638A patent/EP0707581B1/en not_active Expired - Lifetime
- 1994-06-30 DE DE69401823T patent/DE69401823T2/de not_active Expired - Fee Related
- 1994-06-30 AT AT94921638T patent/ATE149163T1/de not_active IP Right Cessation
- 1994-07-04 MA MA23564A patent/MA23254A1/fr unknown
- 1994-07-04 ZA ZA944807A patent/ZA944807B/xx unknown
- 1994-07-04 IL IL11020494A patent/IL110204A0/xx unknown
- 1994-07-04 AP APAP/P/1994/000653A patent/AP463A/en active
- 1994-07-05 TW TW083106150A patent/TW297023B/zh active
-
1996
- 1996-09-23 US US08/717,957 patent/US5834494A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69401823D1 (de) | 1997-04-03 |
| EP0707581A1 (en) | 1996-04-24 |
| TW297023B (cg-RX-API-DMAC7.html) | 1997-02-01 |
| AP9400653A0 (en) | 1994-07-31 |
| ATE149163T1 (de) | 1997-03-15 |
| WO1995001976A1 (en) | 1995-01-19 |
| AU7228394A (en) | 1995-02-06 |
| JPH08512299A (ja) | 1996-12-24 |
| US5834494A (en) | 1998-11-10 |
| IL110204A0 (en) | 1995-01-24 |
| CA2166624A1 (en) | 1995-01-19 |
| GB9313913D0 (en) | 1993-08-18 |
| DE69401823T2 (de) | 1997-08-28 |
| ZA944807B (en) | 1996-01-04 |
| EP0707581B1 (en) | 1997-02-26 |
| CN1129937A (zh) | 1996-08-28 |
| AP463A (en) | 1996-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA23254A1 (fr) | Procede de preparation de nouveaux composes | |
| MA22923A1 (fr) | Procede de preparation de nouveaux composes . | |
| MA23270A1 (fr) | Procede pour la preparation de nouveaux composes. | |
| MA22922A1 (fr) | Procede pour la preparation de nouveaux composes . | |
| MA23792A1 (fr) | Procede pour la preparation de nouveaux composes | |
| MA24011A1 (fr) | Procede pour la preparation de nouveaux composes | |
| MA22970A1 (fr) | Procede de praparation de nouveaux composes. | |
| MA23802A1 (fr) | Procede pour la preparation de nouveaux composes | |
| MA24426A1 (fr) | Procede pour la preparation de nouveaux composes | |
| MA24427A1 (fr) | Procede pour la preparation de nouveaux composes | |
| MA22955A1 (fr) | Procede pour la preparation de nouveaux composes . | |
| MA23309A1 (fr) | Procede de preparation de nouveaux composes. | |
| FR2764603B1 (fr) | Procede de preparation de composes de type ceramides | |
| MA22860A1 (fr) | Procede pour la preparation de nouveaux composes. | |
| EP0833814A4 (en) | Process for the preparation of hydroxyalkylamides | |
| MA24355A1 (fr) | Procede de preparation de nouveaux composes | |
| MA23041A1 (fr) | Procede de preparation de composes benzopyraniques substitues. | |
| MA23036A1 (fr) | Procede pour la preparation de composes. | |
| ITMI931680A1 (it) | Procedimento per la preparazione di alcansolfonammidi | |
| FR2768725B1 (fr) | Procede de preparation du 2-chloroprop-1-ene | |
| FR2626883B1 (fr) | Procede de preparation de n-phosphonomethyl-imino-diacetique | |
| EP0823904A4 (en) | Process for the preparation of spiroindolines | |
| MA24245A1 (fr) | Procede pour la preparation de nouveaux composes sulfonylures | |
| NO940171L (no) | Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal | |
| MA22927A1 (fr) | Procede pour la preparation de nouveaux composes. |